
According to Benzinga Pro data, during Q1, Hims & Hers Health (NYSE:HIMS) posted sales of $101.31 million. Earnings were up 47.85%, but Hims & Hers Health still reported an overall loss of $16.25 million. In Q4, Hims & Hers Health brought in $84.70 million in sales but lost $31.16 million in earnings.